Karen Marie Johnson serves as Executive at Oncology Institute, Inc., where they oversee executive responsibilities. Since joining the company, Karen Marie Johnson has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 20, 2025 involved receiving (via award) 47,840 shares valued at $0.
Karen Marie Johnson currently holds 251,249 shares of Oncology Institute, Inc. (TOI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karen Marie Johnson has been a net neutral trader of TOI stock. They have purchased $0 and sold $0 worth of shares.
Karen Marie Johnson's most recent insider trade was on Nov 20, 2025, when they sold 47,840 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 26, 2023 | TOI | $0 | Award | 52,000 | $N/A | Discretionary |
| Mar 17, 2023 | TOI | $0 | Award | 19,685 | $N/A | Discretionary |
| Nov 17, 2022 | TOI | $0 | Award | 22,708 | $N/A | Discretionary |
| Mar 21, 2022 | TOI | $0 | Award | 4,798 | $N/A | Discretionary |
| Mar 21, 2022 | TOI | $0 | Award | 15,994 | $N/A | Discretionary |